Jeff Garro
Stock Analyst at Stephens & Co.
(0.69)
# 4,075
Out of 5,179 analysts
60
Total ratings
25.64%
Success rate
-14.88%
Average return
Main Sectors:
Stocks Rated by Jeff Garro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCAT Health Catalyst | Maintains: Equal-Weight | $3.5 → $2 | $1.10 | +81.82% | 5 | Mar 13, 2026 | |
| OPRX OptimizeRx | Maintains: Equal-Weight | $17 → $10 | $6.60 | +51.52% | 5 | Mar 6, 2026 | |
| DH Definitive Healthcare | Maintains: Equal-Weight | $3 → $2 | $1.05 | +90.48% | 2 | Feb 27, 2026 | |
| CERT Certara | Maintains: Overweight | $15 → $12 | $5.75 | +108.70% | 6 | Dec 12, 2025 | |
| PRVA Privia Health Group | Reiterates: Overweight | $32 | $20.02 | +59.84% | 6 | Dec 4, 2025 | |
| EVH Evolent Health | Reiterates: Equal-Weight | $9 | $2.21 | +307.24% | 6 | Sep 24, 2025 | |
| PHR Phreesia | Reiterates: Overweight | $32 | $10.98 | +191.44% | 9 | Sep 3, 2025 | |
| SLP Simulations Plus | Maintains: Overweight | $28 → $20 | $11.43 | +74.98% | 2 | Jul 15, 2025 | |
| TBRG TruBridge | Reiterates: Equal-Weight | $28 | $14.07 | +99.00% | 3 | Apr 10, 2025 | |
| VEEV Veeva Systems | Reiterates: Overweight | $280 | $172.59 | +62.23% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $55 | $23.69 | +132.17% | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $250 | $163.85 | +52.58% | 2 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $17.57 | -3.24% | 1 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $28 | $5.14 | +444.75% | 2 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $16.62 | +20.34% | 3 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $5 → $3.9 | $7.91 | -50.70% | 2 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $3 | $0.59 | +405.31% | 3 | May 6, 2022 |
Health Catalyst
Mar 13, 2026
Maintains: Equal-Weight
Price Target: $3.5 → $2
Current: $1.10
Upside: +81.82%
OptimizeRx
Mar 6, 2026
Maintains: Equal-Weight
Price Target: $17 → $10
Current: $6.60
Upside: +51.52%
Definitive Healthcare
Feb 27, 2026
Maintains: Equal-Weight
Price Target: $3 → $2
Current: $1.05
Upside: +90.48%
Certara
Dec 12, 2025
Maintains: Overweight
Price Target: $15 → $12
Current: $5.75
Upside: +108.70%
Privia Health Group
Dec 4, 2025
Reiterates: Overweight
Price Target: $32
Current: $20.02
Upside: +59.84%
Evolent Health
Sep 24, 2025
Reiterates: Equal-Weight
Price Target: $9
Current: $2.21
Upside: +307.24%
Phreesia
Sep 3, 2025
Reiterates: Overweight
Price Target: $32
Current: $10.98
Upside: +191.44%
Simulations Plus
Jul 15, 2025
Maintains: Overweight
Price Target: $28 → $20
Current: $11.43
Upside: +74.98%
TruBridge
Apr 10, 2025
Reiterates: Equal-Weight
Price Target: $28
Current: $14.07
Upside: +99.00%
Veeva Systems
Mar 6, 2025
Reiterates: Overweight
Price Target: $280
Current: $172.59
Upside: +62.23%
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $55
Current: $23.69
Upside: +132.17%
Dec 20, 2024
Initiates: Overweight
Price Target: $250
Current: $163.85
Upside: +52.58%
Dec 9, 2024
Initiates: Buy
Price Target: $17
Current: $17.57
Upside: -3.24%
Jul 26, 2023
Reiterates: Equal-Weight
Price Target: $28
Current: $5.14
Upside: +444.75%
Aug 5, 2022
Maintains: Overweight
Price Target: $15 → $20
Current: $16.62
Upside: +20.34%
May 11, 2022
Maintains: Underweight
Price Target: $5 → $3.9
Current: $7.91
Upside: -50.70%
May 6, 2022
Maintains: Neutral
Price Target: $4 → $3
Current: $0.59
Upside: +405.31%